Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
RGNX
RGNX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
RGNX News
Multiple Companies Experience Significant Stock Price Gains
May 22 2026
NASDAQ.COM
REGENXBIO to Participate in Investor Conferences
May 18 2026
PRnewswire
REGENXBIO Q1 2026 Earnings Call Highlights
May 15 2026
seekingalpha
RGX-202 Clinical Trial Achieves Significant Success
May 14 2026
Yahoo Finance
REGENXBIO Q1 Results Fall Short of Expectations Amid FDA Concerns
May 14 2026
stocktwits
Regenxbiopress Reports Q1 2026 Financial Results with Significant Losses
May 14 2026
seekingalpha
Regenxbio's Gene Therapy Shows Significant Clinical Data
May 14 2026
seekingalpha
REGENXBIO Reports Q1 2026 Financial Results and Operational Highlights
May 14 2026
PRnewswire
FDA Leadership Shakeup May Impact Biotech Stocks
May 08 2026
stocktwits
REGENXBIO to Present Gene Therapy Advances at ASGCT 2026 Meeting
May 07 2026
PRnewswire
REGENXBIO to Report Q1 2026 Financial Results
May 06 2026
PRnewswire
REGENXBIO to Report Q1 2026 Financial Results on May 14
May 06 2026
Newsfilter
Notice of REGENXBIO Securities Class Action
Apr 14 2026
PRnewswire
Capricor's Former Executive Considered for FDA Biologics Chief
Apr 14 2026
stocktwits
Regenxbio Faces Class Action for Securities Fraud
Apr 13 2026
Globenewswire
Regenxbio Faces Class Action Lawsuit Reminder
Apr 13 2026
PRnewswire
Show More News
